Brief: Centogene Receives FDA Emergency Use Authorization For Covid-19 Molecular Diagnostic Test
02/07/2020 13:41
July 2 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
COVID-19
MOLECULAR DIAGNOSTIC TEST
Source text for Eikon: ID:nGNX2PSs2Z
Further company coverage: 39K.MU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice